Francis I Perier Jr
CIK 1304404 · Chief Financial Officer · last filed 2025-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
909 THIRD AVENUE
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Chief Financial Officer | 0 | $46.99 | $0 | $0 | 11 | 2025-07-02 |
| Forest Laboratories, LLC (FRX) Delisted | EVP - Chief Financial Officer | 90,630 | $12.00 | $1.09M | -$1.38M | 25 | 2013-12-10 |
Recent Filings · Page 2 of 4
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-04 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-07-03 | — | Mixed | −85,651 | $0 | |
| 2013-12-10 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −5,316 | -$299.5K | EDGAR |
| 2013-12-09 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −3,493 | -$195.1K | EDGAR |
| 2013-08-23 | Forest Laboratories, LLC (FRX) Delisted | Sell (S) | −12,000 | -$516.0K | EDGAR |
| 2013-05-23 | Forest Laboratories, LLC (FRX) Delisted | Grant (A) | +18,633 | $0 | EDGAR |
| 2013-05-17 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −1,259 | -$48.9K | EDGAR |
| 2012-12-20 | Forest Laboratories, LLC (FRX) Delisted | Gift (G) | −600 | $0 | EDGAR |
| 2012-12-12 | Forest Laboratories, LLC (FRX) Delisted | Sell (S) | −15,942 | -$582.1K | EDGAR |
| 2012-12-11 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −9,850 | -$352.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.